CLEANClean Science and Technology Limited
Chemicals · Specialty Chemicals · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Clean Science and Technology Limited, together with its subsidiaries, manufactures fine and specialty chemicals in India, China, the Americas, Europe, and internationally. It operates through Performance Chemicals, FMCG Chemicals, and Pharmaceutical & Agro Intermediates segments. The company offers performance chemicals, including monomethyl ether of hydroquinone, butylated hydroxy anisole, tertiary butyl hydroquinone, hindered amine light stabilisers, and butylated hydroxytoluene, as well as clean antiOX 962, 4-oxo tempo, 4-butoxy tempo, clean light stab 770, 4-hydroxy tempo, l-ascorbyl palmitate, 2,5-di-tertiary butyl hydroquinone, and dimethyl sebacate. It also provides FMCG chemicals, such as 4-methoxy acetophenone, anisole, guaiacol, butylated hydroxy anisole, l-ascorbyl palmitate, tertiary butyl hydroquinone, para di-methoxy benzene, and ortho methoxy toluene. In addition, the company offers pharmaceutical and agro intermediates, which include guaiacol, dicyclohexyl carbodiimide, veratrole, DHDT, para benzoquinone, para di-methoxy benzene, anisole, and ortho methoxy toluene. It exports its products and serves polymers, coatings, food, automotive, construction, cosmetics, personal care, fragrances, pharmaceuticals, agrochemical manufacturers, specialty chemical firms, and other industries. The company was incorporated in 2003 and is headquartered in Pune, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
The picture
- • ROCE: 17.5%
- • Debt/Equity: 0.00
- • Promoter holding: 54.4%
- • RSI: 57
- • Price vs EMA21: above
- • Price vs SMA50: above
- • Cup & Handle signal (setup quality 70%)
Bull case
- • ROCE: 17.5%
- • Debt/Equity: 0.00
- • Promoter holding: 54.4%
- • RSI: 57
Bear case
- • Revenue growth: -5.5% YoY
- • Profit growth: -21.4% YoY
- • MACD: bearish
- • Golden cross setup: SMA50 below SMA200
Key risks
- • Revenue growth: -5.5% YoY
- • Profit growth: -21.4% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹24.54). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.